Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A

The Prostate
Sumit BhattacharyyaJoanne K Tobacman

Abstract

In tissue microarrays, immunostaining of the enzyme arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase) was less in recurrent prostate cancers and in cancers with higher Gleason scores. In cultured prostate stem cells, decline in ARSB increased Wnt signaling through effects on Dickkopf Wnt Signaling Pathway Inhibitor (DKK)3. The effects of androgen exposure on ARSB and the impact of decline in ARSB on Wnt signaling in prostate tissue were unknown. Epithelial and stromal tissues from malignant and normal human prostate were obtained by laser capture microdissection. mRNA expression of ARSB, galactose-6-sulfate-sulfatase (GALNS) and Wnt-signaling targets was determined by QPCR. Non-malignant human epithelial and stromal prostate cells were grown in tissue culture, including two-cell layer cultures. ARSB was silenced by specific siRNA, and epithelial cells were treated with stromal spent media following treatment with IWP-2, an inhibitor of Wnt secretion, and by exogenous recombinant human Wnt3A. Promoter methylation was detected using specific DKK3 and ARSB promoter primers. The effects of DHT and of ARSB overexpression on DKK expression were determined. Cell proliferation was assessed by BrdU incorporation. Normal stroma s...Continue Reading

References

Jan 1, 1990·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·B RadhakrisnamurthyG S Berenson
May 19, 2005·Cancer Research·Dimitri LodyginHeiko Hermeking
Dec 20, 2007·Journal of Cellular and Molecular Medicine·T NakamuraK Matsumoto
Feb 6, 2008·The Prostate·Christoph ZenzmaierPeter Berger
Feb 21, 2008·The Journal of Biological Chemistry·Sumit BhattacharyyaJoanne K Tobacman
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Eun-Ju LeeJe-Ho Lee
Jan 23, 2009·Cancer Metastasis Reviews·Carmela RicciardelliDavid J Horsfall
Oct 11, 2011·Biochimica Et Biophysica Acta·Jürgen Veeck, Edgar Dahl
Jul 10, 2013·Prostate Cancer and Prostatic Diseases·L FefermanJ K Tobacman
Feb 11, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Leo FefermanJoanne K Tobacman
Dec 17, 2014·Biochimica Et Biophysica Acta·Sumit BhattacharyyaJoanne K Tobacman
Dec 23, 2015·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Min Su KimSoon Chul Myung
Jan 19, 2016·Journal of Theoretical Biology·Hemn MohammadpourSaeed Khalili
Mar 19, 2016·General and Comparative Endocrinology·Sonja Bissegger, Valerie S Langlois
Jul 25, 2017·PloS One·Jack L LeonardKarl J Simin
Oct 31, 2017·Cancer Biomarkers : Section a of Disease Markers·Leo FefermanJoanne K Tobacman
Aug 4, 2018·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Sandra PohlThorsten Schinke
Oct 26, 2018·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Minseok SeoCraig P Hersh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.